GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » Inventories, Raw Materials & Components

CS Medica AS (STU:8G8) Inventories, Raw Materials & Components : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS Inventories, Raw Materials & Components?

CS Medica AS's inventories, raw materials & components for the quarter that ended in Sep. 2024 was €0.00 Mil.


CS Medica AS Inventories, Raw Materials & Components Historical Data

The historical data trend for CS Medica AS's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS Inventories, Raw Materials & Components Chart

CS Medica AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial - - - - -

CS Medica AS Quarterly Data
Sep19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CS Medica AS Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


CS Medica AS Business Description

Industry
Traded in Other Exchanges
N/A
Address
Indiakaj 10, Copenhagen, DNK, 2100
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines